N Carliner, D P Denune, C S Finch, L I Goldberg. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Arm/blood supplyCaffeine/adverse effectsCaffeine/therapeutic useErgotamine/adverse effectsErgotamine/therapeutic useFemaleFerricyanides/administration & dosageFerricyanides/therapeutic useHumansInfusions, ParenteralIschemia/chemically inducedIschemia/drug therapyLeg/blood supplyMethodsMiddle AgedNitric Oxide/administration & dosageNitric Oxide/therapeutic useSuppositories/adverse effectsSuppositories/therapeutic useTartrates/adverse effectsTartrates/therapeutic useVascular Headaches/drug therapyVasodilator Agents/administration & dosageVasodilator Agents/therapeutic use
Substances: See more » FerricyanidesSuppositoriesTartratesVasodilator AgentsNitric OxideCaffeineErgotamine
Year: 1974 PMID: 4859658
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272